These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34905620)

  • 1. Booster effect after SARS-CoV-2 vaccination in immunocompromised hematology patients with prior COVID-19.
    Piñana JL; Garcia-Sanz R; Martino R; Garcia-Roa M; Martin-Martin GA; Risco-Gálvez I; Tormo M; Martinez-Barranco P; Marcos-Corrales S; Calabuig M; Conesa V; Teruel A; Ruiz-Pérez S; Solano C; Navarro D; Cedillo Á; Sureda A
    Blood Adv; 2022 Jan; 6(3):848-853. PubMed ID: 34905620
    [No Abstract]   [Full Text] [Related]  

  • 2. Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients.
    Piñana JL; Vázquez L; Martino R; de la Cámara R; Sureda A; Rodríguez-Veiga R; Garrido A; Sierra J; Ribera JM; Torrent A; Mateos MV; de la Rubia J; Tormo M; Díez-Campelo M; García-Gutiérrez V; Álvarez-Larrán A; Sancho JM; MartínGarcía-Sancho A; Yañez L; Pérez Simón JA; Barba P; Abrisqueta P; Álvarez-Twose I; Bonanad S; Lecumberri R; Ruiz-Camps I; Navarro D; Hernández-Rivas JÁ; Cedillo Á; García-Sanz R; Bosch F
    Leuk Lymphoma; 2022 Mar; 63(3):538-550. PubMed ID: 34668835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of booster vaccination with inactivated COVID-19 vaccines against SARS-CoV-2 Omicron BA.2 infection in Guangdong, China: a cohort study.
    He X; Zeng B; Wang Y; Pang Y; Zhang M; Hu T; Liang Y; Kang M; Tang S
    Front Immunol; 2023; 14():1257360. PubMed ID: 37915583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 S1 Subunit Booster Vaccination Elicits Robust Humoral Immune Responses in Aged Mice.
    Kim E; Khan MS; Ferrari A; Huang S; Sammartino JC; Percivalle E; Kenniston TW; Cassaniti I; Baldanti F; Gambotto A
    Microbiol Spectr; 2023 Jun; 11(3):e0436322. PubMed ID: 37162333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facing the Omicron variant-how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review.
    Külper-Schiek W; Piechotta V; Pilic A; Batke M; Dreveton LS; Geurts B; Koch J; Köppe S; Treskova M; Vygen-Bonnet S; Waize M; Wichmann O; Harder T
    Front Immunol; 2022; 13():940562. PubMed ID: 36091023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric hematology/oncology physician and nurse practitioner attitudes towards the COVID-19 vaccines: A qualitative study.
    Miller ME; Rahim MQ; Coven SL; Jacob SA; Zimet GD; Meagher CG; Ott MA
    Hum Vaccin Immunother; 2022 Nov; 18(5):2048560. PubMed ID: 35344683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of COVID-19 Incidence and Severity Among Adults Vaccinated With 2-Dose mRNA COVID-19 or Inactivated SARS-CoV-2 Vaccines With and Without Boosters in Singapore.
    Ng OT; Marimuthu K; Lim N; Lim ZQ; Thevasagayam NM; Koh V; Chiew CJ; Ma S; Koh M; Low PY; Tan SB; Ho J; Maurer-Stroh S; Lee VJM; Leo YS; Tan KB; Cook AR; Tan CC
    JAMA Netw Open; 2022 Aug; 5(8):e2228900. PubMed ID: 36018588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low mortality in vaccinated immunocompromised haematology patients infected with SARS-CoV-2.
    Shaw B; Shortt J; Low M; Rogers B; Kaplan Z; Fedele P; Gregory G; Vilcassim S; Gilbertson M; Grigoriadis G; Opat S
    Intern Med J; 2022 Dec; 52(12):2172-2175. PubMed ID: 36436197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.
    Peeters M; Verbruggen L; Teuwen L; Vanhoutte G; Vande Kerckhove S; Peeters B; Raats S; Van der Massen I; De Keersmaecker S; Debie Y; Huizing M; Pannus P; Neven K; Ariën KK; Martens GA; Van Den Bulcke M; Roelant E; Desombere I; Anguille S; Goossens M; Vandamme T; van Dam P
    ESMO Open; 2021 Oct; 6(5):100274. PubMed ID: 34597941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of SARS-CoV-2 IgG antibody levels in hematology-oncology patients after COVID-19 vaccination.
    Özsoy M; Yalçin S; Varlibaş A; Çifci A; Cesur S; Aksoy A; Berkem R
    Eur Rev Med Pharmacol Sci; 2024 Feb; 28(4):1624-1631. PubMed ID: 38436195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies and safety considerations of booster vaccination in COVID-19.
    Meng H; Mao J; Ye Q
    Bosn J Basic Med Sci; 2022 Jun; 22(3):366-373. PubMed ID: 35366790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 vaccine-induced humoral and cellular immunity in patients with hematologic malignancies.
    Haggenburg S; Hofsink Q; Rutten CE; Nijhof IS; Hazenberg MD; Goorhuis A
    Semin Hematol; 2022 Oct; 59(4):192-197. PubMed ID: 36805887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequently Asked Questions on Coronavirus Disease 2019 Vaccination for Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Recipients From the American Society for Transplantation and Cellular Therapy and the American Society of Hematology.
    Khawaja F; Papanicolaou G; Dadwal S; Pergam SA; Wingard JR; Boghdadly ZE; Abidi MZ; Waghmare A; Shahid Z; Michaels L; Hill JA; Kamboj M; Boeckh M; Auletta JJ; Chemaly RF
    Transplant Cell Ther; 2023 Jan; 29(1):10-18. PubMed ID: 36273782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program.
    van Leeuwen LPM; Grobben M; GeurtsvanKessel CH; Ellerbroek PM; de Bree GJ; Potjewijd J; Rutgers A; Jolink H; van de Veerdonk FL; van Gils MJ; de Vries RD; Dalm VASH;
    Front Immunol; 2024; 15():1390022. PubMed ID: 38698851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Burden of COVID-19 in the Immunocompromised Patient: Implications for Vaccination and Needs for the Future.
    Antinori A; Bausch-Jurken M
    J Infect Dis; 2023 Aug; 228(Suppl 1):S4-S12. PubMed ID: 37539764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effectiveness of different primary vaccination courses on mRNA-based booster vaccines against SARs-COV-2 infections: a time-varying cohort analysis using trial emulation in the Virus Watch community cohort.
    Nguyen VG; Yavlinsky A; Beale S; Hoskins S; Byrne TE; Lampos V; Braithwaite I; Fong WLE; Fragaszy E; Geismar C; Kovar J; Navaratnam AMD; Patel P; Shrotri M; Weber S; Hayward AC; Aldridge RW
    Int J Epidemiol; 2023 Apr; 52(2):342-354. PubMed ID: 36655537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-Cell Mediated Response after Primary and Booster SARS-CoV-2 Messenger RNA Vaccination in Nursing Home Residents.
    Schiavoni I; Palmieri A; Olivetta E; Leone P; Di Lonardo A; Mazzoli A; Cafariello C; Malara A; Palamara AT; Incalzi RA; Onder G; Stefanelli P; Fedele G;
    J Am Med Dir Assoc; 2023 Feb; 24(2):140-147.e2. PubMed ID: 36587928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 infection following booster vaccination: Illness and symptom profile in a prospective, observational community-based case-control study.
    Antonelli M; Penfold RS; Canas LDS; Sudre C; Rjoob K; Murray B; Molteni E; Kerfoot E; Cheetham N; Pujol JC; Polidori L; May A; Wolf J; Modat M; Spector T; Hammers A; Ourselin S; Steves C
    J Infect; 2023 Dec; 87(6):506-515. PubMed ID: 37777159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversified humoral immunity and impacts of booster vaccines: SARS-CoV-2 antibody profile and Omicron BA.2 neutralization before and after first or second boosters.
    Zhang XS; Windau A; Meyers J; Yang X; Dong F
    Microbiol Spectr; 2024 Oct; 12(10):e0060524. PubMed ID: 39162540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.